Additional Target Fees. Enzon shall pay Santaris an aggregate of US$3,000,000 for the six (6) Additional Targets designated by Enzon pursuant to Section 5.2 upon the expiration of the Reservation Period.
Appears in 3 contracts
Samples: License and Collaboration Agreement (Enzon Pharmaceuticals Inc), License and Collaboration Agreement (Evivrus, Inc.), License and Collaboration Agreement (Enzon Pharmaceuticals Inc)
Additional Target Fees. Enzon shall pay Santaris an aggregate of US$3,000,000 for the six (6) [**Redacted**] Additional Targets designated by Enzon pursuant to Section 5.2 upon the expiration of the Reservation Period.
Appears in 1 contract
Samples: License and Collaboration Agreement (Evivrus, Inc.)
